| Air Pollution Linked to Autoimmune Diseases |
|
|
|
| Sunday, 31 January 2010 12:23 |
|
Though genetic factors have been found for autoimmune diseases, this knowledge has not helped to prevent them. In fact, according to researcher Stacy Ritz of the Northern Ontario School of Medicine, autoimmune diseases are rising at a dramatic rate. "Population-level genetic changes cannot explain this trend; thus, environmental factors are strongly implicated," says Ritz in a recently published study. "Among the possible environmental contributors to autoimmune disease, air pollution exposure has received very little attention. Although there is only a small amount of published data directly examining a possible causal relationship between air pollution exposure and autoimmunity, data from related fields suggests that it could facilitate autoimmunity as well." Antonella Zanobetti, a senior research scientist at the Harvard School of Public Health found that particulate matter in air pollution from industrial combustion and traffic significantly increased hospital admissions for cardiac problems, respiratory disease, and diabetes. There are over 80 autoimmune diseases. Some of the more common ones include type 1 Diabetes, certain Thyroid and Adrenal disorders, Multiple Sclerosis, Scleroderma, Rheumatoid arthritis, Lupus, and Sjogren's Syndrome. Autoimmune diseases are characterized by an immune response which leads to the destruction of the body´s own organs and tissues. They are frequently endocrine system related. Essentially the body treats its organs and tissues as though they were a foreign invader and the immune system kicks in to kill off the invader. Many chemical pollutants are known endocrine disruptors. Though dose specific exposures may be considered safe, little research has been done on the cumulative and synergistic effects of the many multiple and unavoidable exposures humans are subjected to each day. On a daily basis, humans are exposed to a chemical cocktail of pesticides, herbicides, automobile exhaust, and industrial pollution. Often overlooked sources of exposure may also be found in the home in the form of cleaning solutions, fragranced products, air freshener chemicals, and chemicals used in the manufacture of furniture, carpet, plastics, and other household goods. Log in to download a copy of MCSA's newsletter containing the full article, below. Source: MCSA News (2010), "Air Pollution Linked to Autoimmune Diseases", Vol. 5, Issue 2, February |
More articles :
» Chinese Medicine Used In The Treatment Of Scleroderma
According to many proponents of eastern medicine, Chinese medicine is a whole holistic system that can lead to a healthier, happier and more stress free way of living. It is a system that people have benefited from for over twenty-three centuries...
» Special Surgery Scientists To Share Advances in Lupus and Related Conditions
Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of...
» Vitamin D More Important Now, Than Before
Vitamin D is something of a wonder drug, but bad things can happen if your body isn’t getting enough. Those who get adequate levels of vitamin D are better able to ward off everything from cancer to heart disease to autoimmune disease.But here’s...
» New Promising Therapy Against Systemic Sclerosis
There is a new path to defeat systemic sclerosis, also called because of the hardening of the skin of the patients (from Greek skleros, "hard", and derma, "skin"). This path involves the B-cell of the immune system, so far only considered "innocent...
» Autoimmune Diseases
The month of March is designated by the (AARDA) as National Autoimmune Diseases Awareness Month. The goal of the month is to educate the public on the risk factors, prevalence and severe lack of awareness surrounding autoimmune diseases. The theme...
» Active Biotech Presents Data regarding the 57-57 Project at EULAR
Active Biotech (NASDAQ OMX Nordic: ACTI) has presented data from an exploratory clinical trial in Systemic Lupus Erythematosus (SLE) patients at the Annual European Congress of Rheumatology EULAR 2011, an international event for specialists in the...


